| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |